NCT01993433View on ClinicalTrials.gov

A Safety and Efficacy Study of DRM02 in Subjects With Plaque Psoriasis

PHASE2CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

February 28, 2014

Study Completion Date

March 31, 2014

Conditions
Psoriasis
Interventions
DRUG

DRM02

OTHER

Vehicle

Trial Locations (2)

J2B5L4

Clinique Médicale Dr Isabelle Delorme, Drummondville

H2K 4L5

Innovaderm Research, Inc, Montreal

Sponsors

Lead Sponsor

Dermira, Inc.
All Listed Sponsors
lead

Dermira, Inc.

INDUSTRY

NCT01993433 - A Safety and Efficacy Study of DRM02 in Subjects With Plaque Psoriasis | Biotech Hunter | Biotech Hunter